This site is intended for health professionals only

Published on 27 April 2010

Share this story:
Twitter
LinkedIn
RELATED ARTICLES
Reducing steroid use in renal transplant patients
Celgene receives positive CHMP opinion for OTEZLA® (apremilast)
Dupixent hits endpoints in Phase III paediatric trial
Reducing iodine levels in coronary angiography
New drug “alternative to cannabis”

Mucosis Appoints Dr. Roberto Grimaldi As Chief Medical Officer

teaser



Most read

1
User-friendly osteoporosis therapy launched
2
Helapet introduce new, improved 20mm Vented Vial Adapter
3
Feedback: Automation systems in your hospital
4
Merck agrees huge Vioxx settlement
5
Janssen-Cilag’s Stelara approved by NICE



Latest Issue

Read the latest issue >
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:
Twitter
LinkedIn
RELATED ARTICLES
Novartis enters into agreement for exclusive US and Canadian rights to Fanapt
GIA announces the release of a comprehensive global report on Lung Cancer Therapeutics marke
Shire provides update on biologics licence application
Developments in photodynamic therapy
Shire to present at the Deutsche Bank 35th Annual Health Care Conference